80
Views
13
CrossRef citations to date
0
Altmetric
Original Research

Destruction of vasculogenic mimicry channels by targeting epirubicin plus celecoxib liposomes in treatment of brain glioma

, , , , , , , , & show all
Pages 1131-1146 | Published online: 21 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (8)

Yongqing Yang, Nianlan Cheng, Qiao Luo, Ni Shao, Xiaocong Ma, Jifeng Chen, Liangping Luo & Zeyu Xiao. (2023) How Nanotherapeutic Platforms Play a Key Role in Glioma? A Comprehensive Review of Literature. International Journal of Nanomedicine 18, pages 3663-3694.
Read now
Hong-Jun Xie, NorBu Zhan-Dui, Jing Zhao, A. G. A. Er-Bu, Pu Zhen, DongZhi ZhuoMa & Tre Sang. (2021) Evaluation of nanoscaled dual targeting drug-loaded liposomes on inhibiting vasculogenic mimicry channels of brain glioma. Artificial Cells, Nanomedicine, and Biotechnology 49:1, pages 595-604.
Read now
Kamel S. Ahmed, Sun Changling, Xiaotian Shan, Jing Mao, Lipeng Qiu & Jinghua Chen. (2020) Liposome-based codelivery of celecoxib and doxorubicin hydrochloride as a synergistic dual-drug delivery system for enhancing the anticancer effect. Journal of Liposome Research 30:3, pages 285-296.
Read now
Limei Wang, Jin Pei, Zhongcheng Cong, Yifang Zou, Tianmeng Sun, Fionán Davitt, Adrià Garcia-Gil, Justin D Holmes, Caitriona M O’Driscoll, Kamil Rahme & Jianfeng Guo. (2019) Development of anisamide-targeted PEGylated gold nanorods to deliver epirubicin for chemo-photothermal therapy in tumor-bearing mice. International Journal of Nanomedicine 14, pages 1817-1833.
Read now
Rui-Jun Ju, Li-Min Mu, Xue-Tao Li, Cui-Qing Li, Zhan-Jie Cheng & Wan-Liang Lu. (2018) Development of functional docetaxel nanomicelles for treatment of brain glioma. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 1180-1190.
Read now
Rui-Jun Ju, Lan Cheng, Xiao-Ming Peng, Teng Wang, Cui-Qing Li, Xiao-Li Song, Shuang Liu, Jian-Ping Chao & Xue-Tao Li. (2018) Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer. Artificial Cells, Nanomedicine, and Biotechnology 46:sup1, pages 616-628.
Read now
Rui-Jun Ju, Lan Cheng, Xiao Qiu, Shuang Liu, Xiao-Li Song, Xiao-Ming Peng, Teng Wang, Cui-Qing Li & Xue-Tao Li. (2018) Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels. Journal of Drug Targeting 26:9, pages 793-805.
Read now
Débora B Vieira & Lionel F Gamarra. (2016) Getting into the brain: liposome-based strategies for effective drug delivery across the blood–brain barrier. International Journal of Nanomedicine 11, pages 5381-5414.
Read now

Articles from other publishers (5)

Kai Niu, Xie-Wan Chen, Yu Qin, Lu-Ping Zhang, Rong-Xia Liao & Jian-Guo Sun. (2021) Celecoxib Blocks Vasculogenic Mimicry via an Off-Target Effect to Radiosensitize Lung Cancer Cells: An Experimental Study. Frontiers in Oncology 11.
Crossref
Dorina Belotti, Denise Pinessi & Giulia Taraboletti. (2021) Alternative Vascularization Mechanisms in Tumor Resistance to Therapy. Cancers 13:8, pages 1912.
Crossref
Jie Li, Tiantian Tan, Liping Zhao, Mengmeng Liu, Yu You, Yiying Zeng, Dajing Chen, Tian Xie, Lele Zhang, Chaomei Fu & Zhaowu Zeng. (2020) Recent Advancements in Liposome-Targeting Strategies for the Treatment of Gliomas: A Systematic Review. ACS Applied Bio Materials 3:9, pages 5500-5528.
Crossref
Justine L. DelgadoChao-Ming Hsieh, Nei-Li Chan & Hiroshi Hiasa. (2018) Topoisomerases as anticancer targets. Biochemical Journal 475:2, pages 373-398.
Crossref
Jia-Shuan Wu, Li-Min Mu, Ying-Zi Bu, Lei Liu, Yan Yan, Ying-Jie Hu, Jing Bai, Jing-Ying Zhang, Weiyue Lu & Wan-Liang Lu. (2017) C-type natriuretic peptide-modified lipid vesicles: fabrication and use for the treatment of brain glioma. Oncotarget 8:25, pages 40906-40921.
Crossref